Meiji Yasuda Life Insurance Co Cuts Stock Holdings in Synopsys, Inc. $SNPS

Meiji Yasuda Life Insurance Co cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 44.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,633 shares of the semiconductor company’s stock after selling 1,320 shares during the period. Meiji Yasuda Life Insurance Co’s holdings in Synopsys were worth $728,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Sankala Group LLC purchased a new stake in Synopsys during the fourth quarter valued at about $25,000. Elevation Wealth Partners LLC raised its holdings in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after purchasing an additional 27 shares during the period. Osbon Capital Management LLC acquired a new position in shares of Synopsys in the 2nd quarter valued at about $25,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Synopsys in the 4th quarter valued at about $28,000. Finally, IMG Wealth Management Inc. purchased a new stake in shares of Synopsys during the 2nd quarter worth about $28,000. 85.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

SNPS has been the subject of a number of research analyst reports. Zacks Research downgraded shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Friday, August 21st. UBS Group set a $570.00 price objective on shares of Synopsys in a research note on Thursday. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research report on Wednesday, August 19th. Robert W. Baird raised shares of Synopsys from a “neutral” rating to an “outperform” rating and raised their target price for the company from $558.00 to $560.00 in a research note on Thursday. Finally, Mizuho reduced their target price on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a report on Thursday. Twelve investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $561.28.

Check Out Our Latest Research Report on Synopsys

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.

Synopsys Stock Performance

Synopsys stock opened at $442.61 on Friday. The firm has a market capitalization of $84.82 billion, a PE ratio of 78.20, a price-to-earnings-growth ratio of 2.60 and a beta of 1.23. Synopsys, Inc. has a one year low of $366.00 and a one year high of $615.79. The stock’s 50 day moving average price is $416.64 and its 200 day moving average price is $440.13. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.32 and a current ratio of 1.34.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. Synopsys’s revenue for the quarter was up 42.4% on a year-over-year basis. During the same quarter last year, the company earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 11.03 EPS for the current fiscal year.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Strong Q3 performance: Synopsys reported adjusted earnings of $3.91 per share versus expectations of $3.67, while revenue reached $2.48 billion, up 42.4% year over year and ahead of estimates. Strength in electronic design automation (EDA) and the Ansys acquisition supported the results. SNPS Q3 Earnings Beat Estimates on EDA and Ansys Strength
  • Positive Sentiment: Higher outlook and AI momentum: Management raised fiscal 2026 guidance, citing accelerating EDA demand, recovering Design IP activity, interest in agentic AI and additional opportunities from integrating Ansys. Fiscal 2026 EPS guidance is $15.04–$15.10, with revenue guidance reportedly raised to approximately $9.72 billion. SNPS Q3 Earnings Call Highlights EDA Acceleration, Outlook Raised
  • Positive Sentiment: Analyst and strategic support: Goldman Sachs, Benchmark and Needham reaffirmed Buy ratings, with price targets ranging from $570 to $600. Elliott Investment Management also reportedly built a multibillion-dollar position, betting Synopsys can narrow its discount to peers. Elliott Bets Multibillion-Dollar Position on Closing Synopsys’ Peer Discount
  • Neutral Sentiment: Commentators view Synopsys as a key supplier to major technology companies, including Nvidia, and believe Ansys has strengthened its competitive moat; however, the acquisition’s full contribution depends on successful integration and future synergies. SNPS in Right Place, Right Time?
  • Negative Sentiment: Valuation and peer concerns: Following the earnings rally, investors are refocusing on valuation, with Synopsys trading at a high earnings multiple. A comparison with PDF Solutions also highlighted stronger growth and margin improvement at the smaller rival, potentially limiting near-term enthusiasm for SNPS. SNPS vs. PDFS: Which Semiconductor Software Stock Has an Edge?

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.